Skip to Content
Morningstar

Janus Henderson Global Life Sciences I JFNIX

Morningstar Medalist Rating
Medalist Rating as of | See Janus Henderson Investment Hub
  • NAV / 1-Day Return 66.01  /  1.08 %
  • Total Assets 4.8 Bil
  • Adj. Expense Ratio
    0.760%
  • Expense Ratio 0.760%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 1,000,000
  • Status Open
  • TTM Yield 0.30%
  • Turnover 21%

USD | NAV as of Oct 02, 2023 | 1-Day Return as of Oct 02, 2023, 11:10 PM GMT+0

Morningstar’s Analysis JFNIX

Will JFNIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Process Pillar

The Process Pillar is our assessment of how sensible, clearly defined, and repeatable JFNIX’s performance objective and investment process is for both security selection and portfolio construction.

People Pillar

The People Pillar is our evaluation of the JFNIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

Parent Pillar

The Parent Pillar is our rating of JFNIX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Janus Henderson Global Life Sciences I's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings JFNIX

More JFNIX Holdings
  • Current Portfolio Date
  • Equity Holdings 101
  • Bond Holdings 0
  • Other Holdings 26
  • % Assets in Top 10 Holdings 31.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

UnitedHealth Group Inc

6.05
295,799,314
Healthcare

AstraZeneca PLC

4.18
204,196,357
Healthcare

Eli Lilly and Co

3.63
177,455,466
Healthcare

Sanofi SA

2.89
141,206,631
Healthcare

Merck & Co Inc

2.89
141,161,895
Healthcare

Abbott Laboratories

2.69
131,360,924
Healthcare

Thermo Fisher Scientific Inc

2.37
115,699,106
Healthcare

Novo Nordisk A/S Class B

2.36
115,187,470
Healthcare

Boston Scientific Corp

2.28
111,464,832
Healthcare

Novartis AG ADR

2.27
111,075,976
Healthcare